ID: h-e37e76c0
Hypothesis
S100B as Active Pathogenic BBB-Disrupting Signal via RAGE/NF-κB/Claudin-5 Axis
S100B operates as a pathogenic DAMP in the perivascular space, binding RAGE on brain endothelial cells to trigger NF-κB-mediated downregulation of claudin-5 and occludin, creating a self-amplifying BBB disruption loop.
neurodegeneration
EvidencePending (0%)📖 5 cit🗣 1 debates✓ 5 support✗ 2 oppose
✓ All Quality Gates Passed
🧪 Overview
S100B operates as a pathogenic DAMP in the perivascular space, binding RAGE on brain endothelial cells to trigger NF-κB-mediated downregulation of claudin-5 and occludin, creating a self-amplifying BBB disruption loop. Longitudinal plasma S100B slope — not single timepoint — is the mechanistically meaningful metric.
🧬 Mechanism
🧬 Curated Mechanism Pathway
Curated pathway from expert analysis
flowchart TD
A["Reactive Astrocyte S100B<br/>Damage-Associated Signal"]
B["RAGE Engagement<br/>NF-kB Activation"]
C["Claudin-5 Suppression<br/>Barrier Junction Weakening"]
D["BBB Permeability Increase<br/>Endothelial Dysfunction"]
E["Peripheral Inflammatory Entry<br/>Neurovascular Injury"]
F["Chronic Neuroinflammation<br/>Feed-Forward BBB Damage"]
A --> B
B --> C
C --> D
D --> E
E --> F
style A fill:#b71c1c,stroke:#ef9a9a,color:#ef9a9a
style D fill:#b71c1c,stroke:#ef9a9a,color:#ef9a9a
style F fill:#b71c1c,stroke:#ef9a9a,color:#ef9a9a⚖️ Evidence
⚖️ Evidence Matrix5 supports2 contradicts
Supports
The S100B Protein: A Multifaceted Pathogenic Factor More Than a Biomarker.
Supports
Postoperative delirium and changes in the blood-brain barrier, neuroinflammation, and cerebrospinal fluid lactate: a prospective cohort study.
Supports
Interfering with S100B-effector protein interactions for cancer therapy.
Supports
CRISPR/dCas9-KRAB-Mediated Suppression of S100b Restores p53-Mediated Apoptosis in Melanoma Cells.
Supports
The Multifaceted S100B Protein: A Role in Obesity and Diabetes?
Contradicts
S100B interpretation is affected by compartmental kinetics and blood-brain barrier dynamics, weakening a simple one-to-one pathogenic BBB-disruption readout.
Contradicts
Serum BBB markers including S100B can change after seizures, illustrating limited disease specificity for neurodegenerative BBB disruption.
📖 Linked Papers
No linked papers recorded for this hypothesis yet.
🏥 Translation
🧬 3D Protein Structure — S100B
No curated PDB or AlphaFold mapping for S100B yet. Search RCSB →
🧠 GTEx v10 Brain ExpressionJSON
Median TPM across 13 brain regions for S100B from GTEx v10.
💉 Clinical Trials
No clinical trials data linked to this hypothesis yet.
No curated ClinVar variants loaded for this hypothesis.
Run scripts/backfill_clinvar_variants.py to fetch P/LP/VUS variants.
No DepMap CRISPR Chronos data found for S100B.
Run python3 scripts/backfill_hypothesis_depmap.py to populate.
🏆 Tournament
🏆 Arenas / Elo
No arena matches recorded yet. Browse Arenas →
📊 Market Indicators
7d Trend
↔
Stable
7d Momentum
▲ 0.2%
Volatility
High
0.0756
Events (7d)
2
Price History
▼5.0%💾 Resource Usage
LLM Tokens
1,559,664
$5.2824
API Calls
260
Total Cost
$5.2824
🔮 Predictions
🔎 Predictions vs Observations2 predictions · 0 with recorded observations
| Prediction | Predicted | Observed | Status | Conf |
|---|---|---|---|---|
| IF patients with traumatic brain injury (TBI) are stratified by longitudinal plasma S100B slope (increasing >20% per day vs. decreasing <5% per day) over 5 days post-injury, THEN the increasing-slope | Ktrans values and QAlb will be ≥50% higher in the increasing S100B-slope group, with correlation coefficient r≥0.6 between S100B slope magnitude and permeabilit | — no observation — | pending | 0.65 |
| IF a RAGE antagonist (e.g., FPS-ZM1) or function-blocking anti-S100B antibody is administered to mice with verified plasma S100B elevation (>50 ng/mL), THEN brain endothelial NF-κB nuclear translocati | ≥50% reduction in brain endothelial NF-κB activation and ≥80% restoration of claudin-5 expression compared to vehicle-treated controls with matched S100B levels | — no observation — | pending | 0.70 |
🔮 Falsifiable Predictions (2)
pendingconf 70%
IF a RAGE antagonist (e.g., FPS-ZM1) or function-blocking anti-S100B antibody is administered to mice with verified plasma S100B elevation (>50 ng/mL), THEN brain endothelial NF-κB nuclear translocation (p-p65/p65 ratio in nuclear fraction) will decrease by ≥50% and claudin-5 protein expression will
Predicted outcome: ≥50% reduction in brain endothelial NF-κB activation and ≥80% restoration of claudin-5 expression compared to vehicle-treated controls with matched S1
Falsification: No significant change in NF-κB activation or claudin-5 expression after RAGE/S100B blockade; BBB permeability remains elevated despite reduced signaling.
pendingconf 65%
IF patients with traumatic brain injury (TBI) are stratified by longitudinal plasma S100B slope (increasing >20% per day vs. decreasing <5% per day) over 5 days post-injury, THEN the increasing-slope cohort will exhibit significantly higher BBB permeability on dynamic contrast-enhanced MRI (Ktrans i
Predicted outcome: Ktrans values and QAlb will be ≥50% higher in the increasing S100B-slope group, with correlation coefficient r≥0.6 between S100B slope magnitude and p
Falsification: No significant difference in Ktrans or QAlb between S100B slope groups; inverse relationship (higher S100B slope with lower BBB permeability); correlation r<0.3 between S100B slope and permeability ma
▸Metadatasource: v1_phase_c_backfill · origin_type: gap_debate
| source | v1_phase_c_backfill |
| origin_type | gap_debate |
| _schema_version | 1 |
📊 Evidence Profile
Evidence Balance
+0%
Certainty
0%
Debates
0
Incoming
0
Outgoing
0
0 supporting
0 contradicting
0 neutral
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.